Drug intelligence / Profile preview

Acti-C

Development stage: Unknown
Lead developer: Activo Health
Administration: Oral

Overview

**Acti-C** is an oral over-the-counter immune-support nutraceutical marketed by Activo Health as an immune booster. Publicly available product-pipeline information identifies it as an immune-support product, but does not specify its complete ingredient composition, dosage form, or a defined molecular target/mechanism. ([activo.co.za](https://www.activo.co.za/))

Brand names: Acti-C
Other names: Acti C

Targets

ACVR1C (Activin A Receptor Type 1C)ACVR2A (Activin receptor type 2A)ACVR2B (Activin receptor type IIB)

Beyond the preview

Go deeper on Acti-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acti-C.

Explore the full profile